A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
Novartis
Novartis
Johnson & Johnson Enterprise Innovation Inc.
Janssen Pharmaceutica N.V., Belgium
Johnson & Johnson Enterprise Innovation Inc.
Johnson & Johnson Enterprise Innovation Inc.
Monteris Medical
Merck Sharp & Dohme LLC
Akamis Bio
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Inovio Pharmaceuticals
CytoDyn, Inc.
Hoffmann-La Roche
AstraZeneca
NeuGATE Theranostics
Graegis Pharmaceuticals Ltd
Coordination Pharmaceuticals, Inc.
Tactical Therapeutics, Inc.
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
BioMimetix JV, LLC
DEKA Biosciences
BeiGene
EMD Serono
Eurofarma Laboratorios S.A.
Eurofarma Laboratorios S.A.
Kiromic BioPharma Inc.
Adlai Nortye Biopharma Co., Ltd.
Merck Sharp & Dohme LLC
EpicentRx, Inc.
BeiGene
Basilea Pharmaceutica
NantCell, Inc.
Denovo Biopharma LLC
InnoBM Pharmaceuticals Co., Ltd.
Monteris Medical
Candel Therapeutics, Inc.
EMD Serono
Humanetics Corporation
Bristol-Myers Squibb
EMD Serono
Laminar Pharmaceuticals
CEL-SCI Corporation
Regeneron Pharmaceuticals
Boston Scientific Corporation
Imunon
PharmaEngine
PharmaEngine
BioMimetix JV, LLC
Spectrum Pharmaceuticals, Inc